Published in FDA Law Weekly, November 17th, 2005
The company also announced that it has received regulatory approvals in Belgium to initiate a phase II trial of Hemopure in coronary angioplasty patients and in South Africa to initiate a phase II trial in patients undergoing lower limb amputation.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of FDA Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.